EXOCOBIO
ExoCoBio has been developing innovative therapeutics as well as cosmetic products based on stem cell-derived exosomes.
EXOCOBIO
Industry:
Biotechnology Cosmetics Health Care Pharmaceutical
Founded:
2017-01-01
Address:
Seoul, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.exocobio.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
47 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Apple Mobile Web Clips Icon Font Awesome Nginx AJAX Libraries API Sectigo SSL Sectigo Domain SSL
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Arvinas
Arvinas advances therapies degrading disease-causing proteins for life-threatening diseases, from discovery to commercialization.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
ROME Therapeutics
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.
Current Employees Featured
Founder
Investors List
Focus Assets Management
Focus Assets Management investment in Series C - ExoCoBio
KNOTUS
KNOTUS investment in Series C - ExoCoBio
SBI Investment Korea
SBI Investment Korea investment in Series C - ExoCoBio
Dt&Investment
Dt&Investment investment in Series C - ExoCoBio
K2 Investment Partners
K2 Investment Partners investment in Series C - ExoCoBio
G.N. Tech Venture
G.N. Tech Venture investment in Series C - ExoCoBio
InterVest
InterVest investment in Series B - ExoCoBio
TS Investment
TS Investment investment in Series B - ExoCoBio
CSQUARED
CSQUARED investment in Series B - ExoCoBio
Quantum Venture Partners
Quantum Venture Partners investment in Series B - ExoCoBio
Official Site Inspections
http://www.exocobio.com Semrush global rank: 6.88 M Semrush visits lastest month: 719
- Host name: 119.205.197.94
- IP address: 119.205.197.94
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "ExoCoBio"
ExoCoBio
Established the EXOCOBIO EXOSOME INSTITUTE ExoCoBio. Establishing business foundation. ExoCoBio Inc. / CEO & President : Byong Seung Cho 18-cha, Daeryung Techno Town, 19, โฆSee details»
ExoCoBio - Crunchbase Company Profile & Funding
ExoCoBio closed its last funding round on Aug 25, 2020 from a Series C round. Who are ExoCoBio 's competitors? Alternatives and possible competitors to ExoCoBio may include โฆSee details»
ExoCoBio Company Profile 2024: Valuation, Funding & Investors
ExoCoBio General Information Description. Developer of regenerative medicine and biopharmaceuticals designed to create value for the healthy life of mankind. The company's โฆSee details»
ExocoBio x BENEV | BENEV
ExoCoBio Inc. a global leader who specializes in Next-Generation exosome-based regenerative aesthetics, regenerative medicine, & immunotherapy has now merged with BENEV Company โฆSee details»
ExoCoBio - LinkedIn
ExoCoBio Biotechnology Research ExoCoBio improves the quality of life with exosome-based technology Our Exosomes Your FutureSee details»
EXOCOBIO INC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for EXOCOBIO INC of Seoul, Seoul. Get the latest business insights from Dun & Bradstreet.See details»
ExoCoBio - Products, Competitors, Financials, Employees, โฆ
ExoCoBio (์์์ฝ๋ฐ์ด์ค) develops biopharmaceuticals and cosmeceuticals based on stem cell-derived exosomes. Exosomes are nano-vesicles between 30 and 150 nm, secreted by cells โฆSee details»
ExoCoBio - Funding, Financials, Valuation & Investors - Crunchbase
ExoCoBio has been developing innovative therapeutics as well as cosmetic products based on stem cell-derived exosomes. Search Crunchbase. Start Free Trial . ... How much funding has โฆSee details»
ExoCoBio - VentureRadar
"ExoCoBio is focusing on stem cell-derived exosomes, to develop innovative therapeutic as well as cosmetic products. By active developing cosmeceuticals, regenerative medicine, and โฆSee details»
ExoCoBio - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Nov 10, 2024 ExoCoBio has been developing innovative therapeutics as well as cosmetic products based on stem cell-derived exosomes.See details»
ExoCoBio Company Profile - Office Locations, Competitors ... - Craft
ExoCoBio has 5 employees at their 1 location and $47 m in total funding,. See insights on ExoCoBio including office locations, competitors, revenue, financials, executives, subsidiaries โฆSee details»
Meet ExoCoBio, Our Strategic Partner in Advancing Exosomes
BENEV Exosomes (developed by ExoCoBio) are designed for post treatment recovery, working to soothe inflammation, strengthen and improve skin barrier function, and revitalize the skin for โฆSee details»
Byong Seung Cho, CEO โ ExoCoBio - PharmaBoardroom
Apr 8, 2022 ExoCoBio's CEO, Byong Seung Cho, went from biotech venture capital to setting up ExoCoBio, a company whose core technology is based on adipose stem-cell derived โฆSee details»
Exosome News: ExoCoBio Completes Acquisition of Benev
Jul 12, 2023 "We are very pleased with this important acquisition which will contribute to the fast growth and business expansion of ExoCoBio,โ says Mr. Byong Cho, CEO/CTO of ExoCoBio, โฆSee details»
ExoCoBio, A Leader in Exosome Technology, Completes the โฆ
Jul 12, 2023 ExoCoBio, established in 2017, is the world's leader in exosome-based regenerative aesthetics and medicine. It is one of top 3 exosome biotech companies and โฆSee details»
ExoCoBio - Updates, News, Events, Signals & Triggers - Crunchbase
ExoCoBio has been developing innovative therapeutics as well as cosmetic products based on stem cell-derived exosomes.See details»
ExoCoBio to Build the World's First Clinical Grade Exosome GMP ...
Aug 25, 2021 ExoCoBio is already selling its exosome products in the United States through its long-term partner and exclusive distributor, BENEV Company Inc., which is a California based โฆSee details»
ExoCoBio to Build the World's First Clinical Grade Exosome GMP ...
Aug 25, 2021 ExoCoBio will invest approximately US $20M to build the EGMP facility whose project actually started in 2019, and after two years of intensive preparation its construction โฆSee details»
ExoCoBio - Facebook
ExoCoBio. 2,185 likes · 256 talking about this. ExoCoBio Inc. has been developing innovative therapeutics as well as cosmetic products based on stem cell-derived exosomes. ExoCoBioSee details»
ExoCoBioโs First Global Regenerative Aesthetic Exosome Summit
Aug 16, 2022 This Summit, co-hosted with BENEV company of the US and LG Chem of Korea, will be the worldโs largest event in the exosome industry, and attended by about 150 people โฆSee details»